E18 What’s new in industry and science? Short oral presentations Part 3

Wednesday 13 September 2017
09:00-11:30
COEX Convention & Exhibition Center : Grand Ballroom 101 + 102 3 hours

Organised by the FIP Boards of Pharmaceutical Sciences and Pharmaceutical Practice

Chairs: Gabrielle Wiederkehr (Access Consulting, Switzerland)

Programme

09:00 – 09:05

1) Introduction by the Chair

 

09:05 – 09:30

2) Epigallocatechin-3-gallate prevents acute gout by suppressing nlrp3 inflammasome activation

Hye Eun Lee (Republic of Korea)

 

09:30 – 09:55

3) Alteration of serum glutamate level in male adults with drug resistant epilepsy

Wei Wang (China)

  

09:55 – 10:20

4) Association between abcc8 rs757110 (ser1369ala) gene polymorphism and sulphonylurea response in malaysian type 2 diabetes patients

Navin Kumar Loganadan (Malaysia)

 

10:20 – 10:40 Coffee/tea break

 

10:40 – 11:05

5) Implementing pharmacogenomics in Europe: Design and implementation strategy of the ubiquitous pharmacogenomics consortium

Inge Holsappel (Netherlands)

 

11:05 – 11:30

6) Q & A, discussion and conclusion by the Chair